These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24573957)

  • 1. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan.
    Kikura-Hanajiri R; Kawamura NU; Goda Y
    Drug Test Anal; 2014; 6(7-8):832-9. PubMed ID: 24573957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of new designer drugs and their legal status in Japan].
    Kikura-Hanajiri R; Uchiyama N; Kawamura M; Ogata J; Goda Y
    Yakugaku Zasshi; 2013; 133(1):31-40. PubMed ID: 23292017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of current trends in the abuse of psychotropic substances and plants in Japan.
    Kikura-Hanajiri R; Uchiyama N; Goda Y
    Leg Med (Tokyo); 2011 May; 13(3):109-15. PubMed ID: 21377397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
    J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scheduling of new psychoactive substance the Swiss way: A review and critical analysis.
    Grafinger KE; Bernhard W; Weinmann W
    Sci Justice; 2019 Jul; 59(4):459-466. PubMed ID: 31256819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some new psychoactive substances: precursor chemicals and synthesis-driven end-products.
    Collins M
    Drug Test Anal; 2011; 3(7-8):404-16. PubMed ID: 21755608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey.
    Göl E; Çok I
    Forensic Sci Int; 2019 Jan; 294():113-123. PubMed ID: 30502695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
    Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
    J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
    Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
    Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
    Shanks KG; Dahn T; Behonick G; Terrell A
    J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current situation and issues for analyzing illegal drug products].
    Hasegawa T; Takahashi K; Saijo M; Fukiwake T; Motoki Y
    Yakugaku Zasshi; 2013; 133(1):7-11. PubMed ID: 23292013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
    Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
    Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolving Landscape of Designer Drugs.
    Kacinko SL; Papsun DM
    Methods Mol Biol; 2019; 1872():129-135. PubMed ID: 30350286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products.
    Uchiyama N; Matsuda S; Kawamura M; Shimokawa Y; Kikura-Hanajiri R; Aritake K; Urade Y; Goda Y
    Forensic Sci Int; 2014 Oct; 243():1-13. PubMed ID: 24769262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of new psychoactive substances in Northeast Asia from 2007 to 2015.
    Lee J; Yang S; Kang Y; Han E; Feng LY; Li JH; Chung H
    Forensic Sci Int; 2017 Mar; 272():1-9. PubMed ID: 28088088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designer drugs: a medicinal chemistry perspective.
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of an on-site drug-testing device for the detection of synthetic cannabinoids in illegal herbal products].
    Uchiyama N; Kikura-Hanajiri R; Hakamatsuka T
    Yakugaku Zasshi; 2015; 135(3):535-41. PubMed ID: 25759062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of naphthoylindoles acting on cannabinoid receptors based on their fragmentation patterns under ESI-QTOFMS.
    Sekuła K; Zuba D; Stanaszek R
    J Mass Spectrom; 2012 May; 47(5):632-43. PubMed ID: 22576877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.